Abstract
The translation of nanotechnology-based therapies and products from the laboratory to the clinic requires a multidisciplinary approach. Our two interviewees this month discuss their roles in bringing together diverse groups of scientists to achieve this goal.
Original language | English (US) |
---|---|
Number of pages | 1 |
Journal | Nature Reviews Drug Discovery |
Volume | 8 |
Issue number | 11 |
DOIs | |
State | Published - 2009 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery